Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions NCT00436696 Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Laboratory Biom...
- Children's Oncology Group View Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma NCT00567567 Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Carboplatin
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Isotretinoin
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Thiotepa
Topotecan Hydro...
Vincristine Sul...
- 30 Years Children's Oncology Group View Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma NCT00033293 Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Clinical Observ...
Cyclophosphamid...
Laboratory Biom...
Magnetic Resona...
Prednisone
Therapeutic Imm...
- 8 Years Children's Oncology Group View Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma NCT03057626 Recurrent Neuro...
Stage 2A Neurob...
Stage 2B Neurob...
Stage 3 Neurobl...
Stage 4 Neurobl...
Stage 4S Neurob...
Cytology Specim...
Laboratory Biom...
Quality-of-Life...
5 Years - 50 Years Children's Oncology Group View Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma NCT00026312 Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Aldesleukin
Dinutuximab
Isotretinoin
Laboratory Biom...
Pharmacological...
Quality-of-Life...
Sargramostim
- 30 Years National Cancer Institute (NCI) View Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma NCT01798004 Ganglioneurobla...
Stage 1 Neurobl...
Stage 2 Neurobl...
Stage 2A Neurob...
Stage 2B Neurob...
Stage 3 Neurobl...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Busulfan
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Laboratory Biom...
Melphalan
Mesna
Peripheral Bloo...
Pharmacological...
Topotecan Hydro...
Vincristine Sul...
- 30 Years Children's Oncology Group View Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma NCT01208454 Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Isotretinoin
Laboratory Biom...
Pharmacological...
Vorinostat
- 30 Years National Cancer Institute (NCI) View Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma NCT01798004 Ganglioneurobla...
Stage 1 Neurobl...
Stage 2 Neurobl...
Stage 2A Neurob...
Stage 2B Neurob...
Stage 3 Neurobl...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Busulfan
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Laboratory Biom...
Melphalan
Mesna
Peripheral Bloo...
Pharmacological...
Topotecan Hydro...
Vincristine Sul...
- 30 Years Children's Oncology Group View Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma NCT00904241 Ganglioneurobla...
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Cytology Specim...
Laboratory Biom...
- 30 Years Children's Oncology Group View Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin NCT01175356 Ganglioneurobla...
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
3-Dimensional C...
Autologous Hema...
Busulfan
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide Phosp...
External Beam R...
In Vitro-Treate...
Intensity-Modul...
Iobenguane I-13...
Isotretinoin
Laboratory Biom...
Melphalan
Pharmacological...
Questionnaire A...
Therapeutic Con...
Topotecan Hydro...
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma NCT03057626 Recurrent Neuro...
Stage 2A Neurob...
Stage 2B Neurob...
Stage 3 Neurobl...
Stage 4 Neurobl...
Stage 4S Neurob...
Cytology Specim...
Laboratory Biom...
Quality-of-Life...
5 Years - 50 Years Children's Oncology Group View Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions NCT00436696 Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Laboratory Biom...
- Children's Oncology Group View Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma NCT00567567 Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Carboplatin
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Isotretinoin
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Thiotepa
Topotecan Hydro...
Vincristine Sul...
- 30 Years Children's Oncology Group View